Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting NK Cells to Enhance Melanoma Response to Immunotherapies
Hansol Lee, Inês Pires da Silva, Umaimainthan Palendira, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1363-1363
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Mechanisms of immune activation and regulation: lessons from melanoma
Shelly Kalaora, Adi Nagler, Jennifer A. Wargo, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 195-207
Closed Access | Times Cited: 160
Therapeutic approaches to enhance natural killer cell cytotoxicity
Terran Stenger, Jeffrey S. Miller
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML
Franziska Brauneck, Elisa Seubert, Jasmin Wellbrock, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12919-12919
Open Access | Times Cited: 40
Innate Immune Cells in Tumour Microenvironment: A New Frontier in Cancer Immunotherapy
Changhui Li, Xinyu Yu, Xinyan Han, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110750-110750
Open Access | Times Cited: 6
Determinants of resistance and response to melanoma therapy
Bailey M. Robertson, Mitchell E. Fane, Ashani T. Weeraratna, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 964-982
Closed Access | Times Cited: 5
The role of immunity in insulin resistance in patients with polycystic ovary syndrome
Qixuan Zhang, Zhe Yang, Xiangyang Ou, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Application of adoptive cell therapy in malignant melanoma
Qianrong Hu, Jiangying Xuan, Lu Wang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent manner
Wenjiao Xia, Xin Qi, Mingfeng Li, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 33
Tumor-infiltrating lymphocytes as a prognostic and predictive factor for Melanoma
G Vargas, Neha Shafique, Xiaowei Xu, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 4, pp. 299-310
Open Access | Times Cited: 4
Crosstalk between Metabolic Disorders and Immune Cells
Shinichi Saitoh, Koen van Wijk, Osamu Nakajima
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10017-10017
Open Access | Times Cited: 28
Lymph node metastasis and tumor-educated immune tolerance: Potential therapeutic targets against distant metastasis
Jei‐Ming Peng, Yu‐Li Su
Biochemical Pharmacology (2023) Vol. 215, pp. 115731-115731
Open Access | Times Cited: 10
An AI‐assisted integrated, scalable, single‐cell phenomic‐transcriptomic platform to elucidate intratumor heterogeneity against immune response
Christopher P. Tostado, Lucas Xian Da Ong, Jia Wei Joel Heng, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 3
NK Cells in the Tumor Microenvironment as New Potential Players Mediating Chemotherapy Effects in Metastatic Melanoma
Cinzia Garofalo, Carmela De Marco, Costanza Maria Cristiani
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 22
Morphological and Immunohistochemical Aspects with Prognostic Implications and Therapeutic Targets of Primary Sinonasal Mucosal Melanoma: A Retrospective Study
Cornelia Marina Trandafir, Raluca Maria Cloşca, Mărioara Poenaru, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2863-2863
Open Access | Times Cited: 2
The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy
Fatemeh Hajibabaie, Navid Abedpoor, Shaghayegh Haghjooy Javanmard, et al.
Environmental Research (2023) Vol. 237, pp. 116980-116980
Open Access | Times Cited: 6
P2X7 receptor activation impairs antitumour activity of natural killer cells
Alberto Baroja‐Mazo, Alejandro Peñín‐Franch, Fernando Lucas‐Ruiz, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 1, pp. 111-128
Open Access | Times Cited: 10
Immunomodulatory Function of Interleukin-15 and Its Role in Exercise, Immunotherapy, and Cancer Outcomes
M. Farley, David B. Bartlett, Tina L. Skinner, et al.
Medicine & Science in Sports & Exercise (2022) Vol. 55, Iss. 3, pp. 558-568
Closed Access | Times Cited: 10
Aurantii Fructus Immaturus enhances natural killer cytolytic activity and anticancer efficacy in vitro and in vivo
Arum Park, Yun-Jeong Yang, Yunhee Lee, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy
Andrew Knight, Jason J. Luke
Current Oncology Reports (2024) Vol. 26, Iss. 7, pp. 826-839
Closed Access | Times Cited: 1
The role of PD-1/PD-L1 signaling pathway in cancer pathogenesis and treatment: a systematic review
Amirhosein Sabaghian, Shahnam Shamsabadi, Saghar Momeni, et al.
Journal of Cancer Metastasis and Treatment (2024)
Open Access | Times Cited: 1
Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment
Maryam Bahmanyar, Mohammad Kazem Vakil, Ghaidaa Raheem Lateef Al‐Awsi, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Mengsi Zhan, Yunqi Guo, Mingwu Shen, et al.
Advanced NanoBiomed Research (2022) Vol. 2, Iss. 12
Open Access | Times Cited: 6
Comparative Expression Profiling Reveals Molecular Markers Involved in the Progression of Cutaneous Melanoma towards Metastasis
Andreea Daniela Lazăr, Sorina Dinescu, Lea Sleiman, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6565-6565
Open Access | Times Cited: 3
The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies
Azadeh Rahimi, Zahra Malakoutikhah, Ilnaz Rahimmanesh, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
EVI2B Is a New Prognostic Biomarker in Metastatic Melanoma with IFNgamma Associated Immune Infiltration
Satoru Yonekura, Kousuke Ueda
Cancers (2021) Vol. 13, Iss. 16, pp. 4110-4110
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top